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Abstract 
 
The aim of this change management project was the implementation of a Maximum 
Surgical Blood Ordering Schedule (MSBOS). Institutional MSBOS’s utilised in many 
hospitals provide a template recommendation for crossmatching of red blood cells 
for a broad range of surgical procedures; however, for many lower risk surgical 
procedures these requirements are almost negligible.  
  
This project utilised the HSE Change model to implement a new guideline for 
elective procedures. Recommendations were taken from literature and stated for any 
elective procedure having greater than 19 cases (N ≥ 19) the following rules would 
apply: transfusion rate less than 5% requires no type and screen specimen 
processed, transfusion rate between 5%-30% a specimen is processed and no red 
blood cells crossmatched, and for procedures with a transfusion rate above 30% a 
specimen is required and red blood cells crossmatched. 
  
Evaluation results were successful with a reduction seen in the number of type and 
screen specimens proceed by the laboratory and a reduction in the number of red 
blood cells crossmatched. The elimination of routine type and screen specimens for 
these procedures and the resultant change to the hospital’s MSBOS could potentially 
result in an estimated saving of € 47,000 per year.  
  
In conclusion, in the absence of a preoperative indication, routine type and screen 
specimens should be eliminated for select lower risk surgical procedures along with 
a selective approach for ordering red blood cells in higher risk procedures. The 
benefits in workload and cost saving mean such measures should be implemented in 
all hospitals with a Blood Transfusion Department.  
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Chapter 1 Introduction 
 
1.1 Introduction 
 
This Organisational Development project is carried out in a Large Acute Hospital, the 
second largest in Ireland and the principal teaching hospital for the Royal College of 
Surgeons in Ireland. It is a National Centre for Neurosurgery, Renal Transplantation, 
Cochlear Transplantation and Alpha 1 Antitrypsin Deficiency. It has multiple supra 
regional specialities as well as being a designated supra regional cancer and 
radiotherapy centre (Hospital Annual Report 2012). The Blood Transfusion 
Laboratory is ISO accredited and the first laboratory of its kind in Ireland to offer 
electronic crossmatch (EC). It is one of the busiest Transfusion laboratories in 
Ireland where in 2013 7,156 red cell units and 1,729 platelet pools were transfused.  
 
In this chapter, the background of the organisational development project and the 
rationale for the change will be discussed for selecting the Organisational 
Dissertation along with the aims, objectives and the nature of the development. 
Chapter 2 relates to the literate review where the main themes will be discussed 
from the relevant literature searched along with its potential application to the 
dissertation. Chapter 3 discusses various organisational development models with 
an overview of the measures taken as per the selected development model through 
its various stages. Chapter 4 discusses the evaluation of the dissertation through 
quantitative analysis and outcomes achieved. Chapter 5 involves a thorough 
discussion of the dissertation including strengths, limitations and recommendations 
followed by an overall conclusion.  
 
This project will determine the efficiency of ordering practices in the Blood 
Transfusion Department leading to improved efficiency and reduction in costs in 
relation to effective blood ordering methods. The idea for this project originates from 
the need for every hospital Blood Transfusion Department to have a Maximum 
Surgical Blood Ordering Schedule (MSBOS). An MSBOS is a table of elective 
surgical procedures which list the number of units of red cells routinely crossmatched 
for that procedure pre-operatively. The schedule was based on a retrospective study 
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of actual blood usage associated with the different surgical procedure.  It aims to 
correlate as closely as possible the amount of blood crossmatched (C) to the amount 
of blood transfused (T). The C:T ratio can be used to monitor the efficiency of the 
scheme in a surgical setting  
 
Within the Transfusion laboratory there is an MSBOS which, at present, shows 
limited adherence and needs revision. A revision of the MSBOS will lead to the 
streamlining of efficiency for this technologically advanced laboratory. While 
guidelines exist for a template MSBOS, it is different depending on the types of 
elective surgery carried out. Due to this the theatre workload is unique to this 
individual hospital, and any MSBOS is different to the Blood Transfusion Laboratory. 
As electronic crossmatch is the option of choice in transfusion medicine, any 
MSBOS constructed and suitable to this blood transfusion laboratory will provide a 
template method for other laboratories to provide guidelines for the creation of 
similar templates. 
 
The change I hope to implement is to draw up a Maximum Surgical Blood Ordering 
Schedule (MSBOS) - a table of elective surgical procedures that lists whether a T&S 
was required along with the number of units of red cells routinely crossmatched for 
that procedure pre-operatively. There is growing thought that there is no requirement 
for red blood cells ordered before an elective procedure in certain instances. 
Substantial evidence exists for the use of transfusion probability criteria for T&S 
guidelines. Data suggests any procedure with more than 19 cases and a transfusion 
rate of ≤ 5% do not need routine Type and Screen (T&S), let alone red blood cells 
(Prichard et al., 2011) 
 
1.2 Background Rationale for the Change Project 
 
The rationale behind this organisational development project is to determine the 
efficiency of blood ordering methods for frequently performed elective surgeries in a 
major Dublin teaching hospital. There is a current system in place where all patients 
are having a routine elective procedure in the hospital have a type and screen (T&S) 
followed by ordering of red blood cells. A T&S test is carried out by the Blood 
Transfusion Department (BTD) to identify a patient’s blood group along with an 
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antibody screen to determine prior antibody production that may cause delays in 
providing red blood cells. Pre-operative crossmatching of blood for elective surgery 
was performed in anticipation of a potential need which may not materialise. Also, for 
some more serious theatre cases red blood cells are ordered that were stored in the 
theatre fridge. This practice increases blood wastage for Blood Transfusion 
Laboratories along with increases in workload.  
 
The rationale for change is twofold. Firstly, the laboratory is looking to reduce that 
number of specimens being sent to the laboratory to be processed and secondly to 
reduce the amount of red blood cells crossmatched for certain low or medium risk 
procedures. A critical consideration when performing a preoperative assessment is 
the potential need for crossmatched blood, and it was hoped that this organisational 
development project will show that for a wide number of cases a T&S is not required 
to proceed with surgery. Feedback from all staff in the Blood Transfusion 
Department has suggested that the number of returned red blood cells suggests that 
crossmatched red blood cells were not routinely required. There are a large number 
of red blood cells returned to the laboratory the following day that have been 
unavailable for crossmatch to other patients. This will reduce the number of days 
until the blood product expires. 
 
The routine requesting of T&S in these cases represents inefficient utilisation of 
resources and has been shown to cause significant delays in surgery. This has been 
shown by a previous internal study with a CT ratio of 7:1.This indicates that the 
number of units crossmatched far exceeds the number of units crossmatched with a 
transfusion rate of 12.5%. Performing a T&S in our institution costs an estimated 
€83. The volume of samples received by the laboratory has become a barrier to 
completing pre-operative T&S on time as large numbers cannot always be 
processed in a sufficient timeframe. It has been reported that between 23% - 75% of 
T&S specimens collected on the day of surgery were completed only after the 
surgical procedure had already commenced, and another 0.8% of cases were 
delayed while either awaiting the completion of a T&S or acquiring antibody 
compatible blood (Friedberg, Jones, & Walsh, 2003). 
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1.3 Aims and Objectives 
 
The aim of this Organisational Development project is the Revision and 
Implementation of a Maximum Surgical Blood Ordering Schedule for a Large Acute 
Hospital. 
 
The objectives are as follows; 
• Specific: identify the most common elective surgical procedures for which red 
blood cells were crossmatched to evaluate blood usage on these procedures 
leading on to a reduction in specimens processed by the Blood Transfusion 
Department. 
• Measurable: Set criteria for ordering red blood cells from the hospital blood 
bank for elective procedures. This will act as a standard to measure 
compliance to determine if clinicians are complying with the MSBOS. 
• Achievable: To draw up an MSBOS and to inform all users of the service of 
the proposed change and obtain buy-in from all service users. 
• Realistic: The dissertation requires no resources to achieve its objectives and 
is a priority for the Blood Transfusion Department and Theatre Admissions. 
• Time Bound: Introduction of the system within one month from which an 
evaluation can be carried out. 
 
1.4 Nature of Change 
 
The organisation impact of this project spreads to surgical admission, elective 
procedure work ups and theatre admissions. It will affect the way that the laboratory 
currently runs and will aim to increase efficiency, reduce duplication and save money. 
The reality of the proposed change will see a system that is more streamlined for real 
emergencies in a manner that is acceptable to service users. In light of the economic 
and manpower burden routine specimens on the blood bank service, the aims of this 
study are to determine if routine T&S is justified for all surgical procedures. And also 
to identify procedures with a low risk of transfusion in which the omission of T&S may 
decrease unnecessary cost and workload without compromising patient safety. 
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Eliminating routine T&S means that crossmatched red blood cells will not be 
available for at least 45 minutes.  Many of the requests are not urgent and can wait 
the 45 minutes needed to process a T&S specimen. Although rare, the possibility of 
an urgent request or major haemorrhage does exist. In such cases, uncrossmatched 
O negative, universal donor blood can be used. There is a constant availability of 
these products in the Blood Transfusion Department. This represents a more cost 
effective solution compared to performing a T&S on all surgical patients. There 
needs to be a selective approach to performing type and screen for elective surgery. 
The current situation sees all patients presenting to theatre requiring a T&S. 
 
The potential threats to the project include; 
• Obtaining full buy-in from all medical teams along without delaying any 
relevant procedures or patient appointments. 
• It must be conveyed to all relevant surgical teams that in cases where a 
patient has an emergency bleed and no T&S is present then it will take 45 
minutes to provide crossmatch compatible red blood cells. O Neg blood is 
available at all times to cover any possible emergency. It is the final decision 
of the surgical team if the patients need a T&S specimen to be processed by 
the laboratory on an individual patient basis. 
• The taking of a T&S has become the standard pre-operative investigation of 
choice with the aim of preventing complications arising from donor-recipient 
blood group incompatibility and identification of the existence of irregular 
antibodies. These habits exist in all hospitals and will need a culture change. 
 
A retrospective review will be performed of all general surgical procedures in this 
tertiary referral hospital from January 2011 to July 2013. Surgical procedure data will 
be obtained from the Hospital Inpatient Enquiry system (HIPE) and procedures 
matched to the MSBOS list. All procedures will be cross referenced with Blood 
Transfusion records. The number of T&S specimens and the number of peri-
operative transfusions will be recorded for each inpatient episode. A peri-operative 
transfusion was defined as any patient receiving red blood cell units the same day as 
the scheduled operation. Procedures with a transfusion probability less than 5% are 
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considered to be lower risk for transfusion, while those >30% are a higher risk of 
transfusion.  
 
1.5 Summary 
 
This organisational change dissertation is concerned with increasing efficiency, 
reducing workload and cost saving in a large Blood Transfusion Laboratory. The 
success of this project will streamline the role Blood Transfusion plays in the support 
of elective procedures.  
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Chapter 2 Literature Review 
 
2.1 Introduction 
 
A literature review can be described as an analysis of scientific materials 
surrounding a subject that requires the reader to assess the study purpose, 
determine the appropriateness and quality of methods used, analysis of questions 
and answers posed in the scientific literature, and a review of the findings with an 
objective review of the findings (Garrard, 2014). The Literature Review carried out as 
part of this project drew on information from Medline, PubMed and Google Scholar. 
Searches of these databases were performed using key words including blood 
transfusion, maximum surgical blood ordering schedule, surgical blood order 
equation, electronic crossmatch, theatre blood usage, blood wastage and 
crossmatch transfusion (CT) ratio. The search period aimed to examine the literature 
from the past 10 years. Also included were seminal articles surrounding the topic 
from the 1970’s when the first introduction of an MSBOS came into effect. The types 
of literature included were journal articles, international guidelines, and textbooks 
surrounding the topic.  
 
Blood Transfusion Laboratories play an important role in modern medicine. Pre-
operative assessment of blood requirements is usually an over assumption as shown 
by many studies. Crossmatching is time consuming, expensive and once performed 
reduces the lifespan along with creating an artificial shortage in blood stocks (Singh 
& Singh, 2011). In the absence of blood and blood donors, thousands of procedures 
could not be performed safely. Allogeneic red cell transfusion remains the mainstay 
management of patients who are, or are considered to be at risk of a surgical bleed. 
The continued development of surgical procedures of a complex nature has 
increased the need for allogeneic blood (Stanworth, Cockburn, Boralessa, & 
Contreras, 2002; Wallis, Wells, & Chapman, 2006). A National Blood Service Study 
in the UK in 1999 aimed to provide data on a medium and long term trends in 
transfusion. It suggests that with an ageing population, combined with lower rates of 
the population donating, need for red blood cells will increase by 20% by 2025. 
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Modern techniques for donor screening mean that blood is proven to be a safe 
option in developed countries. There is a growing pressure on transfusion services 
regarding cost, safety and blood availability. Over the past 15 years the Irish Blood 
Transfusion Service (IBTS) have implemented new procedures for reducing the risks 
associated with transfusion. These tests have included Nucleic Acid Testing for 
Hepatitis C and HIV along with the routine leucodepletion of all cellular products. 
However, these tests have increased the overall cost of red blood cells (“IBTS 
Website,” 2014). This shows a balance is required between safety and cost. 
 
In a similar vein strict procedures for donation as well as, an ageing population 
already limit potential future donors. It has been forecasted that demand will increase 
20% compared to supply within 20 years in the UK (Currie, Patel, McEwan, & Dixon, 
2004) This deficit is predicted to grow to 34% of total demand for red blood cells 
(RBC) needed by 2015 (Greinacher, Fendrich, Alpen, & Hoffmann, 2007). Yearly 
increases in demand have been noted since the 1980’s with the increase in complex 
surgical procedures and the aggressive treatment of haematological and other 
malignancies (Thomson, Farmer, Hofmann, Isbister, & Shander, 2009). Population 
studies show most European countries are showing a shift from younger to older age 
groups. Demographic trends like these predict future demand. Estimations show an 
increase in population ages will result in an 11.8% to 13.9% increase in the 
population group being transfused (Greinacher et al., 2007) 
 
2.2 Allogeneic Transfusion in Surgery 
 
In 2008, there were 1.9 million blood donations in the UK and Ireland. Despite this 
fact, there is still a shortage in supply. It has been identified that new strategies are 
needed to reduce the workload of unnecessary crossmatching. The term Maximum 
Surgical Blood Ordering Schedule (MSBOS) has been described for over 40 years. It 
began as a measure to limit crossmatching. It requires constant updating to take into 
account new surgical procedures and local patterns of surgical allogeneic transfusion 
requirement. It is stated ‘compatible blood should not be made available for surgery 
where usage is <50% of units provided.' Pre-operative crossmatching of red blood 
cells provides a safety measure in the event of a surgical bleed. In practice, this is 
rare, and over ordering is well documented in many surgical specialties (Singh & 
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Singh, 2011). Various studies, including an Irish study (Prichard et al., 2011) have 
shown patients going for elective surgery have minimal transfusion requirements. 
There needs to be a more targeted approach based on relevant clinical data from the 
particular centre, reducing associated blood transfusion costs. 
 
Allied to a residual need for blood to be crossmatched there are hazards associated 
with transfusion. Other non-infectious transfusion hazards also persist including 
acute and delayed haemolytic transfusion reactions, transfusion related acute lung 
injury (TRALI), transfusion associated graft-versus-host disease (TA-GVHD), 
transfusion associated circulatory overload (TACO), as well as immunomodulatory 
effects (Tinmouth, McIntyre, & Fowler, 2008). Specific donor assays have minimised 
but not eliminated infectious disease transmission (Alter & Klein, 2008) 
 
2.2.1 Alternatives to Allogeneic Transfusion in Surgical Patients 
Autologous Blood Donation (ABD) is a collection of blood in a manner similar to 
the collection and storage of blood from volunteers in general use, except that it is 
collected from the intended recipient (Walsh & Prowse, 2007). This is a pre-planned 
for the clinical benefit of the patient where significant blood loss is anticipated. The 
use of autologous blood donation is not recommended unless the clinical 
circumstances are exceptional, for example, rare blood groups where allogeneic 
blood is difficult to obtain. The patients must be candidates for elective surgery, 
where blood transfusion is expected to be needed. The admission and operation 
days must be guaranteed (Voak et al., 2008). Intra-operative and Post-operative 
Cell Salvage: A recent UK study reported that the use of cell salvage in elective 
surgical procedures, such as orthopaedic and cardiac vascular surgeries where 
more than 1 litre of blood loss is could be lost, could result in saving 160,000 units of 
red cells; thus reducing demand on an already stretched blood supply (Seghatchian 
& Solheim, 2007). Acute Normovolaemic Haemodilution is the removal of blood 
from a patient prior to surgery along with simultaneous replacement with crystalloid 
or colloid fluids to maintain circulatory volume (Hairman et al., 1997). While the 
benefits of these alternatives can be seen they are specific to the surgery performed 
and not used to a large degree in this hospital. 
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2.3 Blood Stock Management  
 
In Ireland there is a centralised blood transfusion service with two blood centres, 
Dublin and Cork. The Irish Blood Transfusion Service (IBTS) is the sole supplier of 
blood to Irish Blood Banks, delivering to approximately 60 hospitals. Transfusion 
laboratories have the responsibility to ensure that a Blood Stock Management 
System is in place, so donated blood is used to minimise wastage whilst ensuring 
adequate stock levels (Pereira, 2005). The optimal storage numbers can be 
estimated via daily/weekly usage estimates whilst allowing for emergency situations 
(AABB, 2011). There even exists complicated formulas that cost every step of the 
process and provide insights into the actual cost of transfusion to the hospital. These 
studies involve multidisciplinary teams and are outside the scope of transfusion 
studies (Shander et al., 2010).  
 
Various factors are implicit in inventory management including supply and demand, 
inventory levels both within the blood supplier and hospitals, stock management 
practices and distribution logistics and the cross-match to transfusion (C:T) ratio (J. 
F. Chapman, Hyam, & Hick, 2004). The blood remains in the hospital stock until it is 
electronically cross-matched for a named patient after a doctor’s request.  It is then 
placed in the “issued” inventory and stored in the theatre fridge for that patient until 
the operation. If unused, it returns to “unassigned” stock inventory and is 
electronically cross-matched for another patient. Blood units are usually sorted 
according to age, with oldest units cross-matched for patients most likely to need 
transfusion. In addition to this primary goal of stock management, the blood 
transfusion laboratory is concerned with minimising waste, the maintenance of high 
quality standards and the reduction of shortages. In practice, only just above half of 
the cross-matched blood is transfused, and on average a unit will be cross-matched 
around three times before it is used or outdated (Katsaliaki, 2008). 
 
A hospital blood bank is an example of an inventory management system. It has the 
function of maintaining an adequate blood supply under conditions where demand is 
variable. It is charged with the responsibility of managing storage and distribution of 
red blood cells throughout the hospital in a manner where need is met. There are a 
number of concerns that must be addressed regarding wastage of short dated 
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products and the reduction of expensive emergency orders from the Irish Blood 
Transfusion Service (IBTS) or possible delays in medical procedures. There are 
recommended target wastage levels depending on the activity of the hospital. This 
particular hospital is a Group 1 large regional hospital with a high transfusion activity 
and proximity to the blood supplier. This gives the hospital a wastage target level of 
0.4% by recommended benchmarking (Heddle et al., 2009). Other studies offer 
similar recommendations with contrasting figures for wastage levels with advised 
rates been below 1% for larger hospitals and up to 20% for smaller centres. The 
wastage rates for the IBTS were 1.4% in 2010 (Genoe et al., 2010).  
 
As far back as 1972, Pierskalla developed an optimal policy for a perishable 
inventory and related this to red blood cells (Pierskalla & Roach, 1972). In 1975 
techniques for management along with mathematical inventory theory were used to 
construct models for strategy to be employed in regional blood banks (Cohen & 
Pierskalla, 2003). It is still generally accepted that Pierskalla’s ‘First In, First Out’ 
policy of management, issuing the oldest available unit first, is the best option when 
dealing with red blood cells. More recently, the Blood Stock Management Scheme 
(BSMS) was established in the UK in 2001, a partnership between hospitals and The 
National Blood Service (NBS) with the purpose of collecting from and providing data 
them with information on various aspects of blood inventory management (J. F. 
Chapman & Cook, 2002). Hospitals supply data of the daily unreserved stock, 
wastage rates and transfusion rates. Inventory practice surveys and matching 
responses to data held on stock levels are used by the BSMS has identified factors 
that can lead to the reduction in the number of days stock is held in the inventory. 
These include reductions in the CT ratio (crossmatch-transfusion), a 24 hour 
reservation period and the employment of electronic crossmatch (J. Chapman, 
2007). 
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Figure 2.1: Flow chart of a unit of red blood cells (Katsaliaki, 2008) 
 
 
 
Difficulties encountered in the management of blood stocks include: 
 
Age and perishability 
Blood is a perishable commodity, with a present lifespan of 35 days.  The shorter the 
shelf life of a unit at entry into inventory, the more likely it is to expire unused. 
Transfusion services providing blood for acute-care hospitals with large surgical 
services or active emergency departments often receive units nearing expiration 
because they transfuse large volumes of blood daily. This means that units may not 
have sufficient days left to circulate through the unassigned/assigned loop enough 
times to be transfused and are eventually expired. Available shelf life decreases 
each time a unit is held or crossmatched for a patient who does not use it.  When 
clinicians order more blood that needed, it is unavailable for other patients, which 
may increase the outdated rate. (J. F. Chapman et al., 2004).  
 
The difference between Supply, Demand and Usage 
Blood supply, demand and usage on any given day are random variables.  Demand 
is defined as the number of units requested and placed into assigned inventory, the 
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usage is defined as the number of units transfused (Prastacos, 1984). Demand is 
difficult to predict due to a number of factors not least the very nature of healthcare.  
Factors which influence demand include population demographics, size of the 
hospital, services provided, ordering policies, advances in surgical techniques, and 
initiatives for more appropriate use of red cells (J. F. Chapman et al., 2004). Large 
hospital size, acute-care facilities and active trauma centres often put stress on 
blood inventories.  Large amounts of blood may be ordered for trauma emergencies, 
elective procedures or complicated surgeries but not all the ordered units may be 
used. If not carefully managed, such ordering practices can inflate the inventory and 
lead to wastage. 
 
Cancellation of planned surgeries 
Cancellation of elective surgery wastes valuable resources, including unnecessary 
laboratory investigations. If the blood bank is not informed that a procedure is 
cancelled, units can be unnecessarily issued and stored in the theatre fridge.  In the 
UK, 8% of scheduled elective operations are cancelled nationally within 24 hours of 
surgery. Shortage of operating time was the most prevalent factor for cancellation of 
elective operation in this study (Sanjay, Dodds, Miller, Arumugam, & Woodward, 
2007).  
 
2.4 Legislation and Guidelines 
 
2.4.1 European regulations on blood transfusion and blood transfusion 
alternatives 
The Directive 2002/98/EC of the European Parliament and of the Council of Europe 
set comprehensive binding standards of quality and safety for the collection, testing, 
processing, storage and distribution of human blood and blood components.  Three 
additional directives have also been implemented: Directive 2004/33/EC regarding 
technical requirements for blood and blood components; Directive 2005/61/EC 
regarding traceability requirements and notification of serious adverse reactions and 
events; and Directive 2005/62/EC regarding community standards and specifications 
relating to a quality system for blood establishments.  These directives cover the 
regulation of blood establishment activities, plasma facilities and certain aspects of 
hospital blood banking activity, but they do not cover the clinical aspects of the blood 
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transfusion chain (the usage of blood and blood components and good clinical blood 
transfusion practice). This Directive provided an update on blood safety on a ‘where 
do we go from here basis’ (Robinson, 2007).  
 
2.4.2 Guidelines and Recommendations for Red Cell Transfusion  
The Code of Ethics on Blood Donation and Transfusion (2005), elaborated by the 
International Society for Blood Transfusion and adopted by the World Health 
Organization, clearly states that “genuine clinical need should be the only basis for 
transfusion therapy” and that “patients should be informed of the known risks and 
benefits of blood transfusion and/or alternative therapies and have the right to accept 
or refuse the procedure”  
 
A previous Recommendation Rec (2002) II (Muñoz, García-Erce, Villar, & Thomas, 
2009) of the Committee of Ministers to member states on the hospital’s and 
clinician’s role in the optimal use of blood and red blood cells, requests the 
application of some principles, including the promotion of a national programme of 
education and training, the release of evidence-based national guidelines on the 
clinical use of blood and red blood cells. It also includes the implementation of a 
quality management system by multidisciplinary hospital transfusion committees, the 
promotion of clinical studies at regional and national level,  and the elimination of 
wastage and loss of blood due to technical reasons.  Recommendation Rec (2002) 
11 also encourages the use of alternatives to allogeneic blood transfusion and the 
development of preventative strategies to reduce blood loss.  
 
Clinical transfusion guidelines are tools used to aid clinicians in the appropriate use 
of blood components in the treatment of patients.  These guidelines are not absolute 
rules but will rather guide clinician’s to utilize the most appropriate blood component 
in the treatment of the patient where a transfusion is indicated. Each patient must be 
evaluated individually and if justified, the decision to transfuse is therefore based 
ultimately on a clinical assessment of a specific patient’s condition and appropriate 
laboratory parameters.  The World Health Organisation set out recommendations to 
assist countries establish transfusion guidelines (World Health Organisation).  In 
Ireland, the National Haemovigilance Office (NHO), set up by the IBTS and launched 
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by the Minister for Health and Children in 1999, supports the development of clinical 
guidelines for hospitals in relation to the use of blood components/products.   
 
British Committee for Standards in Haematology (BCSH) Guidelines for 
Perioperative transfusion state that “The objective should be to manage the patient 
so that transfusion is not needed” (Murphy et al., 2001).  Specific measures that may 
be appropriate are the investigation and treatment of anaemia before elective 
surgery, discontinuation of antiplatelet drugs, reversal of anticoagulation, 
consideration of the various strategies of autologous transfusion and the use of 
pharmacological agents to reduce surgical bleeding.  Guidelines for the management 
of acute blood loss during surgery recommend rapid volume replacement including 
red cell transfusion in cases of 40% loss of blood volume (>2000ml in an adult).  Red 
cell transfusion are not indicated where estimates of actual and anticipated 
haemoglobin concentrations are >10g/dl. 
 
2.5 Maximum Blood Ordering Schedule  
 
Crossmatching of red blood cells is performed for elective surgery in anticipation of a 
potential need that may not materialise. The idea of a MSBOS was first introduced in 
the 1970’s as a way of rationalising blood usage via limiting the number of units held 
out of circulation and therefore reducing the risk of wastage (Friedman, Oberman, 
Chadwick, & Kingdon, 1976; Friedman, 1979). Since the introduction of a MSBOS 
there have been repeated reports of reductions in the crossmatching workload of the 
Blood Transfusion Laboratories, in some cases up to 36%. There are large financial 
savings and more efficient use of blood stocks with a reduction in wastage due to 
expiring units (Jayaranee, Prathiba, Vasanthi, & Lopez, 2002).Seminal studies 
(Friedman et al., 1976; Friedman, 1979) examine the total hospital stay of the patient 
while more recent studies describe the particular procedures the patient is 
undergoing.  
 
A MSBOS is a table of elective surgical procedures which lists the number of units of 
red cells routinely crossmatched for a procedure pre-operatively. It is a schedule 
based on a retrospective analysis of actual blood usage associated with the 
individual procedure. It aims to be a correlation of the amount of blood crossmatched 
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and the amount of blood transfused. The crossmatch:transfusion (CT) ratio can be 
used to monitor the efficiency of such schemes in surgical settings (Voak et al., 
2008).  
 
Surgical procedures can normally be divided into two categories; 
a) Those that can be catered for by a type and screen. In such patients, a previous 
blood group and no previous reactions to transfusion or pregnancy, blood is 
readily accessible for crossmatching within minutes. Adoption of a T&S policy for 
more high risk surgeries is satisfactory. It is not designed to predict blood loss 
post-surgery and a requirement based blood ordering protocol will optimise blood 
utilisation efficiency (Al-Benna & Rajgarhia, 2010). 
b) Those for which blood is crossmatched or uncrossmatched according to the 
MSBOS. This system allows for flexibility. 
For patients in the T&S category who have developed antibodies through transfusion 
or pregnancy, antigen negative blood needs to be made available. For a minority of 
patients undergoing elective surgery blood needs to be crossmatched in anticipation 
of a surgical bleed. Any use of electronic crossmatch means that routine 
crossmatching is not justified for elective procedures that have a blood usage <50%. 
The crossmatch transfusion ratio should not exceed 2.5:1 (Shaker, Wijesinghe, 
Farooq, & Artioukh, 2012). 
 
A Sanguinis study examined blood usage in some common procedures in a large 
regional hospital in Europe. The study showed a large variation in transfusion 
practice for common surgical procedures (Sirchia, 1994). McClelland (2004) 
suggests regular comparisons between hospitals transfusion rates for standard 
procedures (McClelland, 1994). A 2007 Austrian Benchmark Study (Gombotz, 
Rehak, Shander, & Hofmann, 2007) describes variability in transfusion rates in 18 
public hospitals. Some patient variables were examined and various 
recommendations made show the need to construct local guidelines or tariffs for red 
cell usage in elective surgery. 
 
2.5.1 Electronic Crossmatch  
Electronic Crossmatch refers to the computer crossmatch where no serological 
testing is performed, and following T&S validation ensures the correct ABO/RhD type 
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blood is issued. Electronic Crossmatch can only be performed for patients who have 
two blood groups completed and who have no historical record of clinically significant 
antibodies (J. F. Chapman, Milkins, & Voak, 2000). Recommendations have been 
aimed at improving cost effective management of the blood supply suggest reducing 
the crossmatch release period to less than 1.5 days. The study further stated that a 
reduction in wastage can be achieved by having a second routine delivery per 
weekday, and increasing the CT ratio to 70%. The crossmatch release period can be 
maximised by using the electronic crossmatch, which contributes to increases in the 
unassigned inventory and decrease wastage (Katsaliaki, 2008). Conversely, one 
reason for keeping assigned stock levels for longer lies in the use of the antiglobulin 
crossmatch as the method of pre-transfusion testing where patients have developed 
clinically significant antibodies (“IBTS Website,”) 
 
Over the past two decades the T&S procedure has gained increasing acceptability 
as a safe and convenient alternative to the antiglobulin crossmatch (Georgsen & 
Kristensen, 1998). A T&S allows the blood bank to not assign specific red blood cells 
to patients, provided that the recipient has no clinically significant antibodies. If a 
transfusion proves necessary, the Blood Bank issues red blood cells from the 
ABO/RhD compatible inventory with only electronic or abbreviated serological 
crossmatch. The T&S allows hospital Blood Banks to meet requests for surgical 
reserves without, or with only a minimal, assigned inventory. This is only permissible 
for patients who have not developed red cell antibodies.  
 
2.6 Summary 
 
The literature has shown the importance of a MSBOS in a pre-operative theatre work 
up as a source of information for doctors. Researchers have explored compliance of 
doctors in various centres, which will be adopted here as a measurement and 
evaluation tool. The literature provided an insight that a MSBOS can be generic in 
template but is individual to each hospital with regular auditing and feedback 
required to improve blood utilisation practices (Dulara, Jangid, Jain, & Jangid, 2014). 
The literature review has given conviction to this proposed project. 
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Chapter 3 Methodology 
 
3.1 Introduction 
 
This chapter briefly describes the change being initiated along with a discussion of 
some general development models. It will outline a model of change chosen along 
with its application to the change project concerned and followed to the point where 
the change process is complete. It is seen in reviews of the literature that successful 
change management, leadership and selection of the right change model are crucial 
to all organisational change in an evolving environment as healthcare. In the 
management of change, it is vital to follow a defined model. For this change project, 
the HSE change model was chosen. The change being carried out will see a change 
to current blood product ordering practices in the hospital as well as a reduction in 
the number of specimens sent to the laboratory for testing. It will see the change 
processes from initiation to planning through to implementation and finally 
mainstreaming. 
 
If a change is not managed, it fails (Kotter, 1996). Change management has 
previously been described as ’the process of continually reviewing an organisation's 
direction, structure, capabilities to serve the ever changing needs of external and 
internal customers (Moran & Brightman, 2001). As a result of its value change 
management is becoming a highly required as a management skill (Senior & 
Fleming, 2006) Although it is accepted as necessity, there have been failure rates 
reported of up to 70% (Balogun & Hope Hailey, 2004). Various reasons for failure 
have been made with the lack of a structure as a key factor due to the wide range of 
contradictory and confusing theories and approaches available. Its important to note 
that Senior and Swailes describe organisational change as understanding ‘the 
triggers that lead people to think that change is needed, and what happens when 
managers try to make change, is essential given the volatile world we live in’ (Senior 
& Swailes, 2010).  
 
There are examples of classic change models that exist and have been applied to 
many change initiatives. Lewins change model describes 3 stages of change called 
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Unfreeze, Change and Freeze. It has been described as being simplistic yet still 
relevant today, and many change models are based on this theory. It is useful as a 
simplified outline when attempting to start a more in-depth insight into change 
management. Kotters change model consists of a sequence of 8 consecutive steps 
to initiate and implement change. Kotters argues that it is important to change step 
by step to allow progress to be made without confusion. Both Lewins (1951) and 
Kotter (1996) models are linear in their approach and seen to propose that change 
progression is inevitable. The change leader felt that Kotters 8 steps, while descibing 
why transformation fails, failed to allow for the complexity of change along with the 
fact that it encourages an ‘early burst’ followed by a lack of energy in the final two 
steps (Cameron & Green, 2009) Another criticism that could be levelled at these two 
change models is that they do not include potential roles of power and politics in 
change processes (Senior & Swailes, 2010) 
 
3.3.1 Why the HSE Change Model? 
The change model chosen as part of this project is the HSE Change Model (HSE, 
2008). It is both processes centred, active and extremely relevant to this project. It is 
made up of 4 key stages: Initiation, Planning, Implementation and Mainstreaming. 
This change approach was chosen as it is based on a Literature Review of best 
practice and experience in healthcare in Ireland specifically. It’s adapted for 
organisational development and has a strong focus on people involved in aspects of 
the change. The drivers for change are unarguable, but nevertheless resistance was 
inevitable and this allows dynamic flexibility to go back to earlier steps. Resistance 
can be integrated easier than in a linear model. There is attention drawn to 
collaboration and this is relevant with many stakeholders involved. The change 
model is drawn from many other past models including Kotter (1995) and the Project 
Management Institute (2004). Public sector managers continue to be expected to 
cope with change in the organisation. Despite this emphasis there has been little 
attention drawn to its management based on experience of what works in practice. It 
is a reflection of other change models with the limitation of being particular to the 
Irish Healthcare sector.  
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Figure 3.1: HSE Change Model (HSE, 2008) 
 
 
3.2 Initiation 
 
Preparing to lead the change 
This stage will lay the foundations for change and develop a strategy for success. 
There needs to be a responsibility developed here on the part of the change leader 
to lead the change. Authentic leadership (Avolio, Walumbwa, & Weber, 2009) is “a 
pattern of transparent and ethical leader behaviour that encourages openness in 
sharing information needed to make decisions and accepting followers’ inputs." As a 
leader, the core purpose of this change was to examine and change blood ordering 
practices by clinicians for general surgical procedures in a large academic teaching 
hospital. The project originates from the need for all Blood Transfusion Laboratories 
to have a Maximum Surgical Blood Ordering Schedule (MSBOS); a is a list of 
procedures along with requirements for red blood cells that will be revised and 
implemented. The current system sees little adherence to the current MSBOS. The 
aim is to establish and implement an MSBOS for an academic teaching hospital 
through a vision translated into change that will affect a number of areas in the 
hospital. 
 
In order to change the nature and the degree of choice about whether to change, or 
not, was addressed. The activities that need to be ended are the practice of over-
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ordering of red blood cells for elective surgery patients. This allows a change for staff 
ordering red blood cells along with a change for laboratory staff in advising new 
guidelines. There was a redesigning of the current MSBOS that has been drawn up 
based on retrospective data correlated and examined. This information has been 
reviewed by the Anaesthetics department in this hospital and guidelines agreed. The 
clear steps of the HSE Change Model serve to guide the process. 
 
There were various management tools used as part of the initiation. A PESTLE 
analysis was completed. This is a primary management tool used to identify external 
drivers for change. It provides a framework for analysis of the ‘broad macro 
environment’ (Johnson, 2008 E). Drivers for change are listed in Appendix 3 Pestle 
Analysis. They are many drivers for change with this project. There are concerns 
surrounding the provision of a blood supply with increased population and a 
decrease in donors along with the Blood Transfusion Departments responsibilities in 
the provision of a safe and accessible blood supply. Red blood cells are expensive 
where in Ireland we have one of the most costly transfusion services anywhere in the 
world. There is a need for blood stock management with blood usage based on 
capacity and demand. While there is no legal provision surrounding blood wastage 
or misuse, it is the responsibility of all Blood Transfusion Laboratories to maximise 
the provision of blood for all potential recipients. 
 
A SWOT Analysis (APPENDIX 4) is a strategic planning tool used to pre-empt 
leverage points consisting of the exploration of opportunities and strengths for 
change versus the weaknesses and threats in an organisation. A SWOT analysis 
can identify issues from strategy development approaches, but can also lead to over 
generalising. They focus the project onto key areas where progress can be made 
along with establishing a need and value to the change. There are several strengths 
and opportunities to this project that can be used to enable change. The strengths of 
this project are savings in time, cost and efficiency. There is backing from 
management and a strong core of staff enabling the change. There are no 
requirements for resources to complete the change. The opportunities lie in the 
alignment to evidence based best practice in the area. These strengths and 
opportunities are sufficient to allow the change process to progress through evidence 
based information and appropriate communication. There are also examples of 
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weaknesses and threats to the change. The disadvantages lie in any change that is 
made to the current system. The change affects high profile service users who may 
be resistant to change. There is not a culture of change in the hospital. The timeline 
for change is short to draft and introduce new criteria and obtaining data from the IT 
system for evaluation is time consuming. 
 
Analyse Stakeholders 
Clarifying the leadership roles and identification of key influencers was the next step 
in the initiation stage. It set out key individuals and their involvement and importance 
to the project. It helps to identify the people whom the change will affect and involve. 
This is described in detail in Stakeholder Analysis Appendix 6. Once all 
stakeholders have been identified it is important to see who has the most impact 
without failing to address all Stakeholders as potential resistors. Leverage points 
have been described as places to intervene in the system (Meadows, 1999). 
Therefore, it can be seen that the people critical to the project are Anesthetic team 
who have the final say on any transfusion requirement along with laboratory staff 
who can provide advice on the new MSBOS. These individuals are essential for 
intervening in the current system. In the current setting, a resource neutral project 
with potential cost benefits would be more likely to be supported. This project will 
have insignificant effects on cost and the potential for long term cost savings. The 
main people that are required to be involved in the redesign process are laboratory 
and theatre team. The roles and responsibilities of those involved have been made 
clear. The laboratory staffs are there to provide advice but ultimately it is theatre staff 
that has the final say. The partnership between Blood Transfusion and theatre is 
already established through monthly Blood Transfusion Committee meetings that 
have attendance from the theatre directorate. Any possible changes have been 
initiated and discussed at this forum. 
 
The greatest impact that this project will have is on theatre staff and any staff 
involved in the pre ordering of red blood cells for elective surgery patients. The 
situation currently sees interns ordering specimens and red blood cells for patients. 
This is very often an over assumption on what will be used. Anesthetic staffs have 
the final say before surgery commences whether a blood or even a specimen is 
required in any particular instance. The people who will be of the greatest help are 
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anesthetic staff who know the current system and can see the benefit of the revised 
system. Laboratory will have assistance, but this will be at a limited value compared 
to the service users. The laboratory staff will act more as allies.  
 
Groups that are likely to resist the change are Anesthetic staff who are more 
comfortable in the knowledge that a specimen has been processed by the laboratory 
and that a set number of units are crossmatched and available in the theatre fridge 
for use. A previous study done in this hospital showed that only 12.5% of blood 
crossmatched for theatre patients was transfused.  
 
The laboratory has the largest vested interest as it will be a saving on the workload 
of the laboratory. It would also see a reduction in the workload of theatre staff. The 
service users are the key voice that needs to be heard as part of the change 
process. The communication process will mostly begin through the Transfusion 
Committee meetings. The group that has the greatest interest are the Anesthetic 
team. 
 
Risk & Issue Analysis 
There has been some issues raised through the retrospective review and are 
essential to the completion of this project.  
Issue 1: Eliminating routine T&S for the set procedures does create some potential 
safety concerns including the fear that, in the absence of routing T&S, blood may not 
be available if required in an emergency. Firstly, it is worth noting that this audit 
measured same day transfusion rates which included intra-operative and peri-
operative need for blood. It does not quantify the urgency of these requests. Many of 
the requests were not urgent and could have waited the 45 minutes needed process 
a T&S sample. Although rare, the possibility of an urgent request or major 
haemorrhage does exist. In such cases, uncrossmatched O negative, universal 
donor blood can be used. This represents a more cost effective solution compared to 
performing a T&S on all surgical patients.  In Beaumont Hospital, an emergency T&S 
can be performed in 45 minutes.  
 
Issue 2: There may be a delay in provision of red blood cells for patient who have 
previously developed red cell antibodies through previous transfusion or pregnancy. 
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In such cases provision of red blood cells is not immediate. Any requirements that 
need to be met in an emergency during theatre will take a number of hours.  
 
Resolution 1: The resolution to this is that this institutions trauma and resuscitation 
protocol dictates that O negative blood is available at all times and can be 
dispatched immediately. There is a stock of O negative blood available within 15 
minutes, meaning that in blood will be available for transfusion in the event of an 
unforeseen emergency requirement. Any further requirements can be met by 
processing of a T&S specimen or ordering of red blood cells from the Irish Blood 
Transfusion Service (IBTS).  
 
Resolution 2: In cases where patients have developed antibodies to previous 
transfusion or pregnancy provision of red blood cells will be delayed. This would 
have been the case even if the patient had a T&S processed pre surgery. Its the 
routine policy to set up a small number of units and nay more would need 
emergency issue. The theatre department have addressed this issue and have said 
that they are willing to accept O Negative blood in cases of emergency. 
 
3.3 Planning 
 
Building Commitment 
The purpose of planning is to determine details of the change and create support for 
the change. The objective of this phase was to gain support and commitment. It is 
imperative to create an environment receptive to change. Leaders must have the 
ability to create a vision and communicate it clearly. The change leader spoke to 
staff through a presentation of rationale and proposal (Appendix 6). Staff members 
were willing to change with some resistance seen which will be discussed later. The 
change leader met with people who were managers in their area and has 
considerable experience, who could provide advice and expertise. The leaders were 
willing to change and engage in the change once the idea had been communicated, 
and their feedback and template guidelines incorporated into the MSBOS. The 
Anaesthetics Department and the Day of Surgery Admission (DOSA) wards are the 
main service users. This is a change to their working practices and it is important 
that consultants in the area approve of the change. The change will see a list of 
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relevant procedures approved and implemented for prescribing doctors to follow. It 
will propose a reduction in the amount of red blood cells ordered for theatre based 
on a retrospective audit. 
 
The process of engagement began in the laboratory. The Chief Medical Scientist 
approved the project and seen it as beneficial to the department and the wider 
hospital. The proposed idea was discussed at the Hospital Transfusion Committee 
Meeting where staff members from relevant areas meet monthly. A retrospective 
audit was conducted to provide a meaningful picture of the change. This was 
developed further with consultation from theatre regarding the findings.  
 
The purpose of this change is to preserve the blood supply and limit the number of 
unnecessary specimens process by the laboratory. Any MSBOS, while a recognised 
tool for all Blood Transfusion Departments, is a unique schedule for all hospitals 
depending on the nature of the elective procedures. The staff at local level will 
provide support of the project as they are familiar with the new schedule and can 
provide advice to any users of the service unfamiliar with the concept in this 
particular hospital. The change will add value to all departments. In the day ward 
there will be a reduction in the number of T&S specimens taken for elective surgery 
patients along with a change in the number of cases where they will pre-operatively 
order red blood cells. For theatre, it will show a reduction in the number of 
specimens taken pre-operatively along with a reduction in the number of requests 
they will have to make to the Blood Transfusion Department. Currently, the majority 
of specimens are taken in the day ward and the majority of blood requests are made 
by theatre.  
 
The readiness and capability for making change are addressed through education 
and meetings on the topic. There are no barriers to this project except resistance. 
There is no new core competencies needed, just a modification of the current 
system. The theatre staffs are used to a system that has been in place, in this 
hospital. It was important that the change leader provide a strong visible and credible 
leadership for a change. This is achieved through communication of evidence 
backed up by best international practice. Following presentation and education 
sessions, the new Maximum Surgical Blood Ordering Schedule was made available 
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to all staff through the Blood Transfusion Guidelines Booklet available to all hospital 
areas in paper and electronic formats. Once education sessions were complete a 
start date was adopted for change. 
 
Resistence 
There were concerns surrounding the availability of red blood cells detailers in the 
initiation stage. This was a major potential resistor previous to the discussion on the 
topic. Even though there was consensus on the topic at first, there was a feeling that 
clinicians would be losing some of their judgements in deciding how many red blood 
cells were ordered. Once this was made clear that these were guideline figures and 
the Blood Transfusion Department was not attempting to assume control there was a 
change in attitude towards the project. There was a development of supporters 
(UZZI and Dunlap, 2005) that became important to the project implementation. The 
Head of Theatre Directorate was on-board along with relevant Anaesthetic 
consultants that met with the Hospital Transfusion Committee. During various 
discussions it became clear that a further step of looking into delays in theatre would 
be a beneficial step that was not initially anticipated. Unfortunately the short time 
frame became a resistor to completing a comprehensive analysis on this step. The 
introduction of the system saw some staff members reluctant to utilise the system. 
The previous system provided a sense of comfort based on potential blood 
requirements that were generally overestimated. The change leader felt that possibly 
the role and operations of the Blood Transfusion Laboratory, along with its 
favourable location close to theatre were not stressed enough. 
 
Determining the detail of the change 
The purpose of determining the detail for change and outline what the organisation 
has in place to facilitate the change. The Blood Transfusion Department has a core 
knowledge surrounding the subject. The previous MSBOS has not been adhered to 
for many years since its previous incorporation. It has provided a constant irritation 
from blood over ordering and unnecessary workload having been widely accepted 
upon its re-drafting. The current interns in the hospital are aware of the change being 
brought about and the affect it has on their pre-operative work ups. It will see a 
reduction in the amounts of specimens taken at this stage. The support of all areas 
involved has increased the readiness and capacity for change. Analysis of the 
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current system versus the proposed system presents a picture of a system that is 
more user friendly, cost saving and beneficial to all parties. The current situation is 
understood in its current capacity and data collected has shown areas for 
improvement. It has not been possible to include all surgical departments at this 
stage, which is an area for development. The Stakeholders in this project have had 
their own input on the change which has been very important in gaining support. The 
evidence that has been provided in the introduction compares poorly with best 
practice. It shows an overuse of the laboratory in terms of specimen taking and 
overuse in cross matched red blood cells. The data has been collected into specific 
disciplines of elective surgeries for comparison. The current process shows trends 
that are above those required for appropriate service delivery and organisational 
effectiveness.  
 
The information provided in the retrospective audit compiled is as accurate as 
possible. It contains all listed elective procedures for a two and a half year period. It 
does not include emergency surgeries. The information obtained shows specimens 
processed by the laboratory and the number of red blood cells cross matched. It is 
impossible to ascertain if red blood cells were transfused pre-, intra-, or post-
operatively. This information is extremely detailed and relevant in this hospital and 
can be linked to experiences and organisational behaviours. The information is 
presented in table format which is easy to decipher via low, medium and high risk 
procedures that will be addressed in the evaluation. All the data provides a valuable 
insight into blood ordering practices and there need for modification, but it must be 
highlighted that at all times it is at the discretion of Anaesthetics what specimen 
requirements and blood product requirements that particular cases have. Every 
patient is different and it is the responsibility of the laboratory to process specimens 
and provide red blood cells in a timely manner where required.  
 
The factors that have emerged from this study see a deficiency in practices 
operating between the Blood Transfusion Department, Day of Surgery Admission 
Ward, and Theatre. There needs to be a change in practice between the areas and a 
culture change in the organisation. The lines of communication are primarily the 
Hospital Transfusion Committee as well as occasions where presentations of 
information can be made Data collected post change was fed back through official 
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channels. The project compiled volumes of data, but this has not transcended 
through to the final data which is concise and manageable. The post data volume is 
significantly less in volume but not in value to the organisation.  
 
3.4 Implementing Change 
 
Developing the Implementation plan 
The structure of the organisation does not necessarily need to change. There is not 
a major shift required in governance, either management or clinical. In the SWOT 
analysis, carried out earlier, the main threat that ranked the highest was the change 
of practice involving high level staff. Once staff members were on-board the change 
leader was confident of successful implementation. There was also confidence the 
results would provide the basis for mainstreaming. 
 
To access the impact of the project there will be a direct comparison between pre 
and post audit figures. Monitoring these figures will show what change has occurred 
and what change will need to be further advances. The sequence of implementation 
that is required for introduction began with an outline of the plan for change followed 
by presentation of evidence based data communicating the change required. The 
parties responsible include the Blood Transfusion Department, Day of Surgery 
Admission ward and Theatre in adhering to best practice. The timeframe for 
completion is a two week period where guidelines will be introduced and audited 
against previous data. The original objectives have been reviewed at this point and it 
has been decided that they should be reviewed to include a focus on delays in 
theatre to be used to measure progress.  
 
The purpose of this step is to ensure that the project is meeting its purpose. There is 
a need to strengthen the partnership between the areas in connection. There a clear 
date for introduction of the scheme 31th March 2014 communicated to all areas. As 
previously mentioned it was clear to all staff that theatre would have the final say on 
any blood product orders. All guidelines were implemented in areas available to all 
staff including the hospital intranet and the Blood Transfusion Guidelines that are 
available in hard copy in all departments. There will not be a focus on individuals and 
their compliance with the system as this is not a true reflection of the varied nature of 
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surgical procedures. The data returned to the areas following the completeness of 
the project will aim to show improvements that can be increased through knowledge.  
The essential element that drives this project from the change project is the fact that 
building new relationships and bringing about new behaviours will have such a 
beneficial effect on all areas. The level of problems arising is limited in the fact that 
theatre users either want red blood cells or they do not need to order red blood cells. 
It is a clinical decision based on experience on their part. The taking of specimens in 
the Day of Surgery Admission ward is more difficult as each rotation of interns will 
not be aware of the system. This will be addresses at the teaching sessions for all 
interns entering the hospital. The hospital has recently embraced a new document 
management system. Any finding will be uploaded for all users of the service to see 
the beneficial nature of the change following the project going into live operation. 
 
3.5 Mainstreaming  
 
The purpose of mainstreaming is to focus on the success of the change. This will lie 
in the findings to be discussed in Chapter 4. The positive findings that will be 
discussed in the evaluation will be used to integrate new behaviours, skills and 
practices. A presentation of the finding has been developed and will be presented to 
theatre and the day ward with the details of the change. This has showed 
encouraging results that need to be communicated to all staff to celebrate success. It 
will reinforce behaviours and hopefully help to further mainstream the change.  
 
3.6 Summary 
 
The chapter traced the change process and the detail involved in this change 
including any modifications to the original plan. The drivers for change were 
discussed, along with the reasons for choosing the HSE Change Model. A key factor 
in driving the change was the planning in the initiation stage to gain support from 
influential stakeholders gaining their support from the outset. The model helped the 
change process to completion through the use of the four C’S of persuasion 
• Credibility – stakeholders, empowering service users 
• Common ground – identifying issues, detailing benefits to all areas 
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• Compelling evidence – literature review 
• Connect -  providing a face for the change, resonance 
Resistance was a serious issue and was met immediately to address concerns. The 
project was difficult to oppose once best practice was outlined, benefits were 
projected and support gained.  
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Chapter 4 Evaluation 
 
4.1 Introduction  
 
This chapter of the dissertation will describe evaluation in relation to this change 
project. There will be discussion surrounding various evaluation methods available 
along with the reasoning for the type of evaluation carried out. The evaluation of this 
project for change would form the basis for permanent introduction for all service 
users through the outcomes achieved. The World Health Organisation describes 
evaluation as “the systematic examination and assessment of the features of an 
initiative and its efforts, in order to produce information that can be used by those 
who have an interest in its improvement or effectiveness” (WHO, 1998). An Irish 
study by Butler states that evaluation can produce the evidence to make informed 
decisions across all levels of an organisation (Butler, 2002). This is particularly 
significant in this change project as it addresses a number of hospital directorates. 
As described by Ovretveit as well as Edmunds & Brown qualitative evaluation looks 
at words and their meanings while empirical numbers and their significance are the 
focus of quantitative analysis. Quantitative is fixed and linear in design where 
measurement is the research instrument. (Edmunds & Brown, 2012; Ovretveit, 2002) 
 
There are a plethora of models and frameworks available proposed to address 
evaluation in a similar vein to the amount of change models. They range from being 
outcome centred, to summative, to goal based, and non-goal based. The change 
leader took the opportunity to focus on quantitative evaluation. A quantitative 
approach was chosen in this instance as the change leader was aware of the 
problems associated with blood ordering practices along with the reasons for a lack 
of adherence to the current MSBOS. It was not being championed by the Blood 
Transfusion Department any longer and had become obsolete. In the work up there 
had been a lot of feedback provided surrounding the current system. The issues at 
hand were clear and did not require understanding beforehand. The benefits of a 
quantitative approach in this instance were that the change was a top down 
approach. Within the initiation stage of the HSE Change Model urgency was stated 
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based on ethical factors of blood wastage and economic factors surrounding the cost 
of red blood cells.  
 
The evaluation will entail dividing elective procedures into those that had a 
transfusion rate of less than and great than 5%. Procedures with a transfusion rate of 
<5% will tackle the aim of reducing specimens and blood orders while procedures 
with a transfusion rate of >5% will focus on the aim of reducing blood ordering. There 
will be a wastage and cost analysis, red blood cells and consumables. This would be 
completed by descriptive statistics that represent quantitative characteristics in 
dealing with the MSBOS. There will be an outcome assessment that makes a 
judgement on whether or not the objectives are being achieved.  
 
Lazenbatt’s description of evaluation is a “method of measuring the extent to which 
an intervention achieves its stated objectives” fits the criteria that have been outlined 
in the aims and objectives of this change initiative. The four C’s described are an 
effective method of evaluation in this instance for interpreting the extent of the 
change (Lazenbatt, 2002); 
• Efficiency -  are aims and objectives attained 
• Effectiveness – have objectives led to achieved outcomes 
• Economy – has all outcomes been achieved 
• Equity – has everyone had an opportunity to achieve outcomes 
 
It must be noted that while this project focuses on reducing the number of red blood 
cells crossmatched for theatre patients along with reducing the number of specimens 
being processed by the laboratory, at all times the decision to transfuse remains a 
clinical one. The nature of theatre means that every patient has a different 
requirement. While guidelines will be implemented there can be no 100% adherence 
to these guidelines. In consultation with theatre there were a number of exclusions 
put forward for patients who need a specimen processed and red blood cells 
provided. These exclusions include; 
• Patients with previously identified plasma antibodies 
• Patients with a Haemoglobin (Hb) <10g/dl 
• Patients with coagulation/platelet disorders 
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• Patients having surgery in another unit off site from the main hospital. 
 
4.2 Elective Procedures with a transfusion percentage less than 5% 
 
In a two and a half year period a previous audit of 1,860 general surgical procedures 
were incorporated into this study (Tables 4.1 and 4.4). The first evaluation focused 
on 1,618 procedures that had a transfusion rate of less than 5% (Table 4.1). Ten 
procedures were identified in which the transfusion probability was <5%. It was 
proposed that these elective procedures would no longer require a Type and Screen 
(T&S) to be processed by the Blood Transfusion Department along no red blood 
cells required. Of 1618 procedures performed, the total number of transfusions was 
21, with an overall transfusion probability of 1.3%.  The percentage of patients 
having T&S performed pre-operatively varied across this range of procedures from 
54.2% (appendectomy) to 98.8% (mastectomy). 
 
Table 4.1: Lower risk surgical procedures 
Surgical Procedure Number of 
Procedures 
Performed 
Number of 
Type and 
Screens 
Number of 
Transfusions 
(Transfusion 
Probability (%)) 
Appendectomy 653 354 (54.2%) 3 (4.6%) 
Cholecystectomy 310 305 (98.4%) 10 (3.2%) 
Hiatus Hernia Repair 35 31 (88.6%) 1 (2.8%) 
Inguinal Hernia Repair 123 79 (64.2%) 3 (2.4%) 
Mastectomy  
[+/- SLNBx or Regional Excision of LN] 
[+ Radical excision of LN of Axillae] 
 
107 
84 
 
104 (97.2%) 
83 (98.8%) 
 
0 (0%) 
2 (2.4%) 
Other Hernia Repairs 61 56 (91.8%) 1 (1.6%) 
Parathyroidectomy 56 48 (85.7%) 0 (0%) 
Thyroidectomy 181 176 (97.2%) 1(0.6%) 
Varicose Vein Stripping 8 6 (75%) 0 (0%) 
SLNBx = Sentinel lymph node biopsy, LN = lymph node 
 
Once these figures were presented to theatre and reviewed by the Anaesthetics 
Department they advised a list of the procedures that they were satisfied would no 
longer require a T&S specimen processed along with no red blood cells required. 
This list (Table 4.2) included nine of the procedures listed above; 
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Table 4.2: Procedures that do not require T&S 
Procedure 
Varicose vein surgery 
Parathyroidectomy (excluding mediastinal exploration) 
Simple mastectomy +/- sentinel lymph node biopsy 
Appendectomy (Laparoscopic & Open) 
Cholecystectomy (Laparoscopic) 
Femoral Hernia Repair  
Inguinal hernia Repair (laparoscopic & Open) 
Repair of SMALL incisional hernia 
Umbilical Hernia Repair 
 
Further to this the Anaesthetics Department also returned a list of further procedures 
they were satisfied would also no longer required a specimen processed under a 
number of different specialities (Table 4.3). This discussion was additional on their 
part and would be included in addition to the original change. 
 
Table 4.3: Additional procedures that do not require a T&S  
Procedure 
General Surgery 
Excision of Pilonidal sinus 
Incision & drainage of abscess 
Formation of AV (Arteriovenous) Fistula 
Axillary lymph node dissection 
Reversal of Ileostomy 
EUA (Examination under Anaesthesia) of rectum 
Injection/banding of Haemorrhoids 
Diagnostic Laparoscopy 
Urology 
Circumcision 
Hydrocelectomy (Unilateral & Bilateral) 
Orchiectomy (Unilateral & Bilateral, excluding abdominal exploration) 
ENT (Ear, Nose and Throat) 
FESS (Functional Endoscopic Sinus Surgery) 
Myringotomy 
Adenoidectomy 
MLB (Micro laryngoscopy and Bronchoscopy) 
Gynaecology 
D&C (Dilation and Curettage) 
Hysteroscopy 
Laparoscopic Oophorectomy (Unilateral & Bilateral, excluding extensive 
tumour resection) 
Neurosurgery 
Lumbar discectomy 
Simple decompressive laminectomy (excluding tumour resection) 
Vagal Nerve Stimulator 
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These procedures would no longer require a T&S specimen to be sent to the Blood 
Transfusion Department. Evaluation was carried out on data collected for two 
elective procedures, Appendectomy and Cholecystectomy, for a two week period 
regarding adherence with the new system. The largest number of specimen’s was 
received on these procedures. Data retrieved is displayed in a Bar Chart (Figure 
4.1) below in a % format. This data shows that for each procedure;  
• Appendectomy elective surgeries showed a reduction in the number of 
specimens from 54.2% to 16.6%. The timeframe for data retrieval for both 
procedures was much smaller than the previous data collected and is 
displayed via a percentage. This included 30 procedures with a total of 6 
specimens received (16.6%).  
• Cholecystectomy elective procedures showed a reduction in number of 
specimens from 98.2% to 38.8%. This included 18 procedures with a total of 7 
specimens received (38.8%) 
 
Figure 4.1: Pre and post specimen numbers (%) 
 
 
 
 
 
 
 
 
36 
 
4.2.1 Evaluation 
This evaluation focused on elective procedures with a transfusion percentage of less 
than 5%. Following Lazenbatt’s 4C’s of evaluation for this section; 
• Efficiency: the aims were to evaluate the ordering practices of blood 
ordering and reduce the number of specimens processed by the 
laboratory and the amount of blood orders. 
• Effectiveness: the objectives were to compile a list of procedures that 
no longer required a T&S specimen. This list was verified by the 
Anaesthetics Department and further added to. 
• Economy: The outcomes of this evaluation were successful. Of the 10 
procedures, it was agreed that 9 would no longer require a specimen. 
In addition, a list of procedures were further added that were also to 
proceed without a specimen. Also Figure 4.1 indicated a reduction in 
the amount of specimens sent to the laboratory in the timeframe. 
• Equity: Upon first presentation of the topic to theatre staff the author 
feels that there may have been an absence of some service users who 
may not have been informed completely surrounding the change. It is 
the goal of disseminating these results will further improve these 
figures. 
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4.3 Elective Procedures with a transfusion percentage greater than 5% 
 
The literature review determined that transfusion rates greater than 5% require a 
specimen to be processed and no red blood cells ordered. Where transfusion rates 
are greater than 30% red blood cells should be crossmatched for these procedures. 
In this section of the evaluation the concern is with blood ordering practice instead of 
the number of specimen’s processed. It contains five procedures that had higher 
transfusion probabilities >5% (Table 4.4). Of 242 high risk surgical procedures 
evaluated, the total number of transfusions was 49, with an overall transfusion 
probability of 20.24%. Individually, the transfusion rates vary from 11.4% 
(adrenalectomy) to 32.7% (oesophagectomy). All procedures had a T&S processed 
and red blood cells had been ordered. 
 
Table 4.4: Higher risk surgical procedures. 
 
Surgical Procedure 
Number of 
Procedures 
Performed 
Number of 
Type and 
Screens 
Number of 
Transfusions 
(Transfusion 
Probability (%)) 
Adrenalectomy 35 35 (100%) 4 (11.4%) 
Elective Laparotomy 8 8 (100%) 1 (12.5%) 
Gastrectomy 73  73 (100%) 20 (27.4%) 
Oesophagectomy 55 55 (100%) 18 (32.7%) 
Mastectomy 
[+ reconstruction, augmentation, 
TAHSO] 
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71 (100%) 
 
6 (8.4%) 
TAHSO = Total abdominal hysterectomy and salpingo-oophrectomy 
 
These procedures would therefore, with a transfusion rate of >5%, require a T&S 
specimen to be processed by the Blood Transfusion Department without red blood 
cells being ordered. The exception would be Oesophagectomy which had a 
transfusion rate of greater than 30%, Oesophagectomy was not analysed beyond 
this point as blood as this procedure required red blood cells to be crossmatched. 
There was an analysis carried out of adrenalectomy, laparotomy and mastectomy 
procedures. 
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Figure 4.2: Pre and post red blood cells ordered (%) 
 
 
These procedures would no longer require red blood cells to be ordered. Following 
introduction of new guidelines data was collected for these elective procedures listed 
in Figure 4.2, for a two week period regarding adherence with the new system. This 
data shows that for each procedure;  
• Adrenectomy elective surgeries showed a reduction in the number of 
procedures that had ordered red blood cells. The timeframe for three 
procedures is much smaller than the previous data collected and is displayed 
via a percentage. In the post study there were 8 procedures with a total of 4 
having red blood cells ordered (50%). Laparotomy elective surgeries showed 
a reduction in the number of procedure that had ordered red blood cells. In 
the post study there were 3 procedures with a total of 1 having red blood cells 
ordered (33.3%) 
• Mastectomy elective surgeries showed a reduction in the number of 
procedure that had ordered red blood cells. In the post study there were 24 
procedures with a total of 7 having red blood cells ordered (29.1%). 
 
4.3.1 Evaluation  
This evaluation focused on elective procedures with a transfusion percentage of 
greater than 5%. Following Lazenbatt’s 4C’s of evaluation for this section; 
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• Efficiency: the aims of this section were to evaluate blood ordering 
practices only. 
• Effectiveness: The objectives were to compile a list of procedures that 
no longer required blood to be ordered pre-operatively. 
• Economy: The outcomes of this evaluation were successful. Figure 4.2 
indicates that there has been a significant reduction in the amount of 
red blood cells ordered for each procedure in the timeframe. 
• Equity: Upon first presentation of the topic to theatre staff the author 
feels that there may have been an absence of some service users who 
may not have been informed completely surrounding the change. It is 
the goal of disseminating these results will further improve these 
figures. 
 
4.3 Costs Involved in Crossmatching Red blood cells 
 
4.3.1 Cost of Processing T&S Specimens 
There was a cost estimate for those procedures that no longer needed a routine 
T&S. Thyroidectomises were excluded as they still requires a T&S. This figure has 
been calculated by multiplying the number of unnecessary T&S specimens 
performed (n=1437) by the laboratory cost of a T&S analysis (€83) and divided by 
2.5 to obtain a yearly average. The economic savings equal €47,708 per year. A 
costing was completed for performing an electronic crossmatch and serological 
crossmatch (2-3% of all patients require this method) of red blood cells (Table 4.5 
and 4.6) 
 
Table 4.5: Cost of electronically crossmatching 4 units of red blood cells. 
Consumable Price € Quantity Cost 
Compatibility 
Labels 
1.05 4 4.20 
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Table 4.6: Cost of serological crossmatching 4 units of red blood cells 
Reagent 
/Consumable 
Price € Quantity 
required 
Cost € 
IgG Card  3.23 ( per card) 1 3.23 
Diamed ID- 
Diluent 
0.76 (per ml) 200µl 0.15 
Anti-Fya Control 2.93 (per ml) 25 µl 0.07 
Tips 0.094 (per tip) 8 0.76 
Segmenters 0.207 (per 
segmenter) 
4 0.83 
Test tubes 0.04 (per tube) 8 0.32 
Compatibility 
labels 
1.05(per label) 4 4.20 
Total Cost  €9.56 
 
4.3.2 Cost of expired units of RBC 
A unit of RBC costs €273.31. At the end of this study, the number of units that had 
been crossmatched and that were returned were examined to see if any units had 
expired. The re-use and expiry rates were calculated as a % of the total no. of units 
returned. The cost of expired units, and percentage contribution to the overall 
wastage in the study period were calculated. A total of 7 units expired January 2001-
June 2011 (Statistics obtained from Transfusion Committee Meetings). 291 units 
were returned to stock with re-use and wastage rates of 97.6% and 2.4% (7 units) 
respectively. Unnecessary crossmatching for this study group directly contributed to 
wastage of 7 units. The cost of expired units was calculated to be €1,931.17 (7 x 
€273.31). This accounted for 43.5% of the wastage in the 6 month study period. 
 
4.4 Summary 
 
This chapter has addressed the issue of evaluating a change process. The 
outcomes of the change suggest successful change initiative in regard to the original 
aims and objectives. In summary, the change leader found that the data collected in 
the post evaluation showed a significant improvement in adherence to the MSBOS 
and also a significant reduction in the number of specimens processed 
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Chapter 5 Discussion 
 
5.1 Introduction 
 
This chapter will provide a review of the change project implemented. This project 
set out to reduce blood product ordering along with a reduction in the number of 
specimens processed by the laboratory. There will be consideration of the strengths, 
as well as the limitations of the study. Working in the environment with over ordering 
of red blood cells was frustrating for all staff involved. It was not difficult to initiate the 
idea of a need for change. The literature review provided substantial information that 
supported a change in practice. While no specific numerical guidelines exist 
specifically for each procedure or speciality, there exists evidence based guidelines 
on creation of a Maximum Surgical Blood Ordering Schedule. It is unique to each 
hospital. The author felt the selection of a single change model that covers all 
aspects of the change was extremely important. The HSE Change Model (HSE, 
2008) was selected as the sole model for change. 
 
It is important to stay focused on the aims and objectives of the change project 
throughout. The aim of this Organisational Development project was the Revision 
and Implementation of a Maximum Surgical Blood Ordering Schedule for a Large 
Acute Hospital. The objectives were as follows; 
• Specific: identify the most common elective surgical procedures for which red 
blood cells were crossmatched to evaluate blood usage on elective 
procedures leading on to a reduction in specimen processed in the Blood 
Transfusion Department. 
• Measurable: Set criteria for ordering red blood cells from the hospital blood 
bank for elective procedures. This will act as the standard to measure 
compliance to determine if clinicians are complying with the MSBOS. 
• Achievable: To draw up a MSBOS and to inform all users of the service of the 
proposed change and obtain buy-in from all service users. 
• Realistic: The dissertation requires no resources to achieve its objectives and 
is a priority for the Blood Transfusion Department and Theatre Admissions. 
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• Time Bound: Introduction of the system within one month from which an 
evaluation can be carried out. 
 
The results from the evaluation indicate that that there is considerable variation in 
transfusion probability for the fifteen general surgical procedures examined; from 0% 
– 32.7%. However, for many of the lower risk surgical procedures the need for 
transfusion is almost negligible. The routine requesting of Type and Screen (T&S) in 
these cases represents inefficient utilisation of resources. Of 1618 lower risk surgical 
procedures performed, the overall transfusion rate was 1.3%. In select procedures, 
this rate was even lower. These represent procedures in which routine T&S may be 
omitted without compromising patient safety.  
 
Substantial evidence exists for the use of transfusion probability as a systemic 
criteria for T&S guidelines. Studies suggest any procedure with greater than 19 
cases (N value ≥ 19) and a transfusion rate of ≤ 5% would not need routine type and 
screening (Dexter, Traub, & Qian, 1999; van Klei et al., 2002). It was proposed that 
all lower risk procedures would no longer require a T&S. These procedures all have 
an N value ≥19 and a transfusion rate of ≤5%. The benefits of reducing T&S include 
reduced demand on staff and laboratory processing time, reduced theatre delays, 
and substantial costs saved. A T&S costs €83 in this hospital. Elimination of routine 
T&S on the selected lower risk procedures has the potential to save €47,000 per 
year. The economic and ethical issues surrounding blood wastage show that a total 
of 7 red blood cells were directly attributable to theatre wastage, totalling almost 
€2000. This is the first study of its kind that has specifically investigated the cost of 
the service provided by the Department. It was an important aside to note the 
various costs involved. The total cost of completing a crossmatch involves; 
• Medical Scientist time (estimated 20 minutes staff time) 
• Portering staff (estimated 15 minutes staff time) 
• Cost per crossmatch - estimated to be €4.20 per electronic crossmatch and 
€9.56 per serological crossmatch (2-3% of theatre crossmatching) 
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However, eliminating routine T&S for the above mentioned procedures does create 
some potential safety concerns including the fear that in the absence of routine T&S, 
blood may not be available if required emergently. Many of the requests were not 
urgent and could have waited the 45 minutes required process a T&S sample. 
Although rare, the possibility of an urgent request or major haemorrhage does exist. 
In such cases, uncrossmatched O negative, universal donor blood can be used. This 
represents a more cost effective solution compared to performing a T&S on all 
surgical patients. The institutional trauma and resuscitation protocol dictates that 
there is an availability of four units of O negative blood are available at all times  A 
further stock of red blood cells can be made available immediately, meaning that in 
blood will be available for transfusion in the event of an unforeseen emergency 
requirement.  
 
5.2 Organisational Impact 
 
The author completed a number of management tools documented in the Appendix 
section at the beginning of the project to set out the current situation and the ideal 
situation upon completion. The author felt that these tools were instrumental in 
understanding the changes necessary and what may be expected. Upon completion 
review of this data indicated a favourable outcome in all aspects. Some omissions 
were made including receiving of feedback from service users. It was felt that the 
system would smooth transition and adherence to the system would be sufficient 
feedback. An example of an area that the author felt needed expansion was 
informing clinicians of the location and service provided by the Blood Transfusion 
Department. It was felt this needed to be stressed much stronger. It is important for 
the author to continue the mainstreaming of this change project.  
 
Behavioural 
Since the implementation of the change many behavioural aspects surrounding the 
change have improved dramatically. A pre audit carried out showed critical 
deficiencies in blood ordering practices. Updating users on the operations of the 
Blood Transfusion Department enables users to understand the service provided 
and enabled a behavioural change. A sense of ownership was thrust upon the 
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department once implementation began leading to improved attitudes and a positive 
behavioural change 
 
Structural 
The evaluation results indicate an improved structure to how the system is managed. 
The change idea behind the project is far less complex than may be expected 
considering the role of the Blood Transfusion Department in the important role it 
provides in blood provision. This is not to understate the Departments role but 
merely to demonstrate that education of users on the service provided can lead to 
substantial changes. The initial presentation demonstrate to staff that the laboratory 
is 400m from theatre and that it will take a porter only approximately 2 minutes to 
make their way to the laboratory and back to theatre. It was estimated by some 
service users that there was a significant distance to be travelled. It was put across 
that the department is immediately available to cover all emergencies. While it was 
part of this initiative that blood may be made available immediately for certain 
procedures, it was assured to staff that; 
• For patients without a T&S specimen processed it will take 45 minutes to 
process a specimen. In the intervening period emergency O Negative red 
blood cells are available. 
• For those patients who have the exclusions listed in the introduction of the 
Chapter 4 red blood cells can be made available, including transport time to 
theatre, in less than 10 minutes 24 hours a day. 
 
Personal 
There will be a continued coordination with the introduction of this change in theatre 
ordering practices. The process needs mainstreaming over a period of time to 
ensure its adherence. There will be renewed confidence in the system once relevant 
findings have been reported back to the service users. They will provide greater 
validity and reliability. There was initial resistance to the project in the sense that 
theatre staff are used to having specimens processed and red blood cells 
crossmatched. There is clearly some resistance in place as the evaluation results, 
while promising, provide some areas for improvement. The aim was never to gain 
100% compliance, an unachievable figure in an unpredictable environment of a 
theatre directorate, but results can be improved upon. The aim was also not to focus 
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on specific staff members but a concerted effort to change practice of a Directorate. 
It is also the case that all staff were not at the initial presentation and may not have 
input into the revised procedures that were made available. Upon meeting staff with 
the change results it would be hoped to encompass more staff, and possibly get 
more on board with positive results. There has been no negative feedback about 
delays in blood provision.  
 
It could be considered that the personality and position of the change leader may 
have had an adverse effect throughout the change in achieving desired results. In 
example, it may have been more appropriate to be more forceful in dealing with 
resistance upon initial introduction of the system. The change leader is not in a 
position of management, which is felt would have assisted in a more positive forceful 
attitude towards the change. The support of the theatre directorate manager made 
up for the change leaders lack of managerial credentials.  
 
Cultural 
Procedures and beliefs make up the culture of an organisation and in an academic 
teaching hospital must have patient care as the shared value at the core of service 
provision. Evaluation results show a shift in culture that can be pushed further. It 
must be championed that the change to new guidelines for blood product ordering 
will improve the institution in driving towards evidence based practice.  
 
5.3 Strengths and Limitations 
 
On reflection, it is felt that this change process was worthwhile, rewarding and 
constructive. The principal strength of this project is that the implemented change 
has achieved its objectives. The aims and objectives were allowed to be answered in 
a short time frame. There are increased efficiencies with regard to processing of 
specimens and a reduction in workload for the laboratory. This manifested itself in 
increased levels of confidence of staff on both sides of the system that no negative 
feedback has arisen. The system is in place for a future study of a particular 
speciality that may lead to even further decreases in specimen processed or red 
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blood cells ordered. The findings of the study can be viewed as a strength, as it 
expands further on another Irish study by Prichard (2011) regarding blood usage.  
 
There are a number of limitations to this study. The timeframe of the change project 
implementation was quite limited. The introduction and implementation were 
thorough and comprehensive, but the evaluation is lacking in comprehensive data to 
support the change. The data collected is promising, and no doubt that further data 
will provide greater validity to the change. Another limitation is that it is difficult to set 
exact figures or goals for compliance, it will never be 100%. It is hoped that through 
continued education and statistical evidence that percentages can continue to lower 
to a threshold level in future evaluations of the system. Future reviews may be able 
to add specific required outcomes based on the complete findings of this change 
management project. The relatively small sample size used for evaluation in the 
current study provides generalisation of results, the reason for this being time 
constraints on the author. 
 
There is one aspect of the project that needs to be addressed. It arose during the 
methods section that delays caused by incomplete laboratory specimens in theatre 
would have added significant credibility to the change project. This was realised 
quite late on and there was not significant time to evaluate such findings. It is felt 
there is definite scope for looking into this area of boundary between theatre, the day 
ward and the laboratory. It was originally not in the objectives, was added to the 
objective section, and subsequently removed.  
 
Attitudes, Barriers and facilitators 
It is extremely important when implementing change to understand attitudes. The 
author found initial positive attitudes do not always correlate to actual behaviour 
shown with some resistance in the evaluation. While barriers will always exist it is up 
to the author to determine the advantages and disadvantages of a change project. 
An author can have positive thoughts and beliefs but they must be backed by 
support to overcome barriers. There are additional factors that could have affected 
the evaluation results and non-adherence including conflict between peers, lack of 
communication, inadequate training and lack of support systems. For any new 
initiative to be put into place successfully, support systems must be put in place. A 
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lack of support systems can act as a barrier (Drennan et al., 2009). Support is a 
broad concept entailing many aspects, yet is vital to any change to work practice and 
expansion of service.  
 
Another area of importance noted was the role of facilitators cannot be understated 
in practice. The stakeholder analysis demonstrated the important staff members that 
could be used as facilitators. The facilitators in place included good working 
relationships, a thrust in the service provided by the laboratory and effective 
communication. The author felt it was important to develop a supporting environment 
was beneficial to influencing behaviour (Ajzen, 2005). 
 
5.4 Resistance 
 
The literature provides explanations towards resistance from high powered clinicians 
and healthcare professionals. It can arise from a lack of understanding to blurring of 
boundaries. Evidence suggests that role development into areas that are traditionally 
medicine can result in blurring of roles and resistance. Resistance from healthcare 
professionals can be reduced with communication and understanding of the roles of 
stakeholders. There were potential barriers at the start of the project that were 
envisaged and strategies were put in place. Pre-implementation strategies (force 
field analysis) prepared a clear and practical plan with a solid grounding in evidence.  
 
Recommendations for future Improvements 
Upon reflection, there are some limitations to the project. The evaluation section 
needs analysis over a longer period of time to add validity to results. The concept of 
an MSBOS is not a new phenomenon, yet there remains a large gap in the literature 
from an Irish perspective. There needs to be further studies carried out in different 
centres to allow a comprehensive evaluation of literature from and would provide 
feedback for completion and avoid groundwork in terms of literature reviews being 
carried out and frameworks established anytime a study of this nature is initiated. It 
is fine to establish guidelines from international studies as a template but would be 
more appropriate with the emergence of new surgical techniques and aimed at a 
population study that is unique to Ireland.  
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The dissemination of findings is often discounted following initial implementation of a 
change project. Findings from the current study will be presented to staff at local 
level and within the theatre and the ward involved in the change. It is the intention to 
submit an abstract to the relevant body for publishing.  
 
5.5 Summary and Conclusion 
 
The need for change was apparent from everyday experience in the current 
environment. Support from the literature was a defining element in the establishment 
of a need for change. It was implemented utilising the HSE Change Model. The use 
and selection of a suitable change model was important to lessen any resisting 
factors. The value of a process centered evaluation focusing on quantitative data 
provided depth and quality to the information. An important indicator of a successful 
change was the decision of the Anaesthetics Department to embrace draft proposals 
the addition of extra procedures. This showed that confidence had been established 
in the change project and that resistance had been overcome. It also gave the author 
great confidence going forward. 
 
This change management process involved the revision and implementation of a 
new Maximum Surgical Blood Order Schedule in the Blood Transfusion Department. 
It was introduced to streamline service, reduce costs and align to best practice in the 
area. Although the initial data collection was time consuming collating necessary 
information, it has been worthwhile and supported by quantitative evidence and 
positive feedback from colleagues. The change represents a more structured 
approach to blood ordering practices in this hospital combined with a reduction in the 
number of specimens taken from patients. 
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Appendices 
Appendix 1 Project Impact Statement 
 
Describe here how things are now in relation 
to the issue 
Describe here how things should (ideally) be when 
the issue has been addressed 
Behavioural : describe current patterns of 
behaviour/ attitudes of the key people 
involved with the issue  
• No adherence to current MSBOS 
• Blood Transfusion Staff do not advise interns 
on over ordering for preoperative patients 
• There is currently no auditing of the system. 
Behavioural: what sort of behaviours would (ideally) 
be evident when the issue has been addressed? 
• Staff are made aware of the MSBOS and adhere to 
its guidelines. 
• Blood Transfusion staff will be aware of the new 
guidelines and can pass on relevant advice to clinical 
staff. 
• There will be a greater deal of auditing to ensure 
compliance. 
Structural: describe the way roles and 
responsibilities are currently organised 
• Currently, the theatre admission staff will 
accept/deny a patient to theatre based on 
patients specimen being processed or 
awaiting completion. 
• Red blood cells supplied based on request 
from clinical staff. 
• The new DOSA ward is currently the location 
for the taking of T&S specimens f 
Structural: describe how roles/responsibilities would 
be organised once this issue has been addressed 
• Patients can be admitted to theatre for certain 
procedures without a specimen being processed by 
the Laboratory. 
• Blood Transfusion Department can provide advice on 
guidelines for certain procedures. 
• The ne DOSA ward will be one of the main targets for 
the new MSBOS.. 
Personal: describe how you participate in and 
contribute to the current reality 
• As part of the Laboratory Directorate I 
participate in the supply of red blood cells. 
• Currently, I have spoken to theatre 
surrounding this topic and the benefits it will 
provide. 
• It will be the responsibility of myself to liaise 
with relevant regarding various aspects of the 
change. 
Personal : describe how you will participate in and 
contribute to the  new  reality 
• An active part in ensuring that that there is 
compliance with the MSBOS.  
• I will continue to liaise with theatre staff and analyse 
any relevant feedback.  
• I hope to engage and participate in the change. This 
will involve being in contact with staff 
Cultural: describe “how things are done 
around here” now, e.g. accepted ways of 
doing things, implicit understandings 
• Clinicians order red blood cells as a safety 
measure for theatre. 
• Blood Transfusion staffs are not currently 
advising clinicians on over ordering of red 
blood cells. 
• Certain understanding at present sees 
clinicians ordering products uninhibited. 
Cultural: what will be “the way things are done 
around here” when the issue has been addressed? 
• Inform Clinicians of the service that the Blood 
Transfusion Department provide. 
• A new MSBOS along be attached to the new Blood 
Transfusion Guidelines. These are available to all 
staff on the hospital intranet page. The future 
situation will see advice passed on, on certain 
procedures. 
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Appendix 2 Force Field Analysis 
 
Stage 1 - Changes in the workplace  
DRIVING FORCES RESTRAINING FORCES 
Stakeholders: The original idea for the 
change project was raised by the head of 
the Surgical Directorate. It is supported 
by the head of the Surgical Directorate 
along with all management in the 
Laboratory Directorate 
Resistance: There will be resistance 
towards this change project as many of 
the practices have been in place for a 
number of years 
 
Reduction in Workload: It will result in a 
reduction in the workload in the for the 
Blood Transfusion Laboratory along with 
a cost saving element. 
Provision of Red blood cells: There may 
be a delay in the provision of Red blood 
cells for patients who do not have a 
specimen processed by the Blood 
Transfusion Laboratory. This need will be 
met via O neg blood being made 
available and requires a risk analysis. 
Updated MSBOS: There is a evidence 
based need to have an updated MSBOS 
in place in every hospital 
Communication: This project requires a 
number of steps to be communicated to 
all parties. The ciommunication needs to 
be filtered to Interns, Nursing staff, 
theatre admission and Anaesthetics who 
have the final say on any change. 
Retrospective Audit Completed:Data has 
already been correlated and analysed to 
show the value of the project. It is from 
this data that relevant recommendations 
will be made. 
Data Analysis:Obtaining a list of 
procedures to audit for post analyis will 
involve learning how to generate theatre 
lists from the HIPE system in the hospital.  
Achievable and Realistic: This project is 
both achievable and realistic. There is a 
need for an updated MSBOS and a 
realistic timeframe for completion and 
evaluation.  
Theatre Admission: It will require a 
change to the theatre admission policy 
where certain procedures will be allowed 
into theatre without a specimen being 
sent to the Blood Transfusion 
Department 
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Force Field Analysis - STAGE 2 Importance and Ease of Change 
 
A IMPORTANCE 
 5      1 
 Very Important to the Change  Of little importance 
 
B EASE OF CHANGE 
1      5 
Very Easy to Change    Very Difficult to Change 
 
DRIVING FORCES 
 
A 
Importanc
e 
B 
Ease of 
Change 
A  * B Ranking 
Stakeholders 5 1 5  
Reduction in Workload 4 1 4  
Updated MSBOS 4 4 16 3 
Retrospective Audit Completed 3 1 3  
Achievable and Realistic 3 2 6  
RESTRAINING FORCES A 
Importanc
e 
B 
Ease of 
Change 
A  * B Ranking 
Resistance 5 4 20 2 
Provision of Red blood cells 5 4 20 1 
Communication 5 3 15  
Obtaining Data 3 2 6  
Theatre Admission 3 5 15  
 
 
STAGE 3:  STRATEGY 
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Priority 1: 
STRATEGY FOR PRIORITY 1 
Provision of Red blood cells 
The provision of red blood cells will be affected by this change project. The current 
situation sees specimens being sent to the laboratory for processing on all patients 
prior to surgery. The new situation would see certain procedures not requiring a 
specimen to be taken. In cases such as these compatible red blood cells would not be 
immediately available for these surgeries. There is a supply of O Neg blood available 
at all times to cover the 45 minute period it would take the laboratory to process an 
emergency specimen. This has been addressed with all parties involved and will 
require a risk assessment. 
 
Priority 2: 
STRATEGY FOR PRIORITY 2 
Resistance 
There is a resistance element to this project that needs to be addressed. The project 
will involve a change to practices of some very senior staff in theatre. These staff 
have many years of experience in a theatre setting and the rationale for change 
needs to be backed up by sufficient evidence to be accepted. 
 
Priority 3: 
STRATEGY FOR PRIORITY 3 
Updated MSBOS 
The change to the MSBOS is the main point being addressed in this project. There is 
much literature surrounding the topic. It has been justified in its need and needs 
investigation, change and evaluation. The project details the changes that need to be 
made for the successful introduction of an updated MSBOS in this centre. 
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Appendix 3 PESTLE Analysis 
 
Political 
Environmental concerns surrounding this 
topic include the reduction in the amount 
of the population donating. There is a 
shortage in the blood supply and evidence 
based data suggests that this will only 
worsen. 
 
The Blood Transfusion Department is run 
under the Department of health and 
follows its mission statement ’to ‘improve 
the health and wellbeing of people in 
Ireland in a manner that promotes better 
health for everyone, fair access, 
responsive and appropriate care delivery, 
and high performance’. The provision of a 
safe and accessible blood supply benefits 
the whole population. 
Economical 
The provision of red blood cells is expensive 
and while the economic state of the 
country should not be a factor as cost 
saving should be employed at any time. 
 
Seasonality plays a role in the provision of 
red blood cells. It is difficult to pin-point 
specific trends where red blood cells will 
definitely be required but preservation of 
stocks will help in any times of shortage. 
 
 
Social 
The provision of red blood cells is based on 
consumer attitudes and demographics 
towards donation. Mobile units that cover 
the country ensure the provision of red 
blood cells. 
 
Major events and influences do not affect 
trends on blood usage. Publicity and media 
coverage can affect the amount of units 
donated. 
 
 
Technological 
There are introductions coming for 
technology for the sector. It is the 
responsibility of each Blood Transfusion 
Laboratory to ensure there stock 
management is in place for future stock 
movement between centres. There is 
innovation approaching that needs to be 
planned for in the area. 
 
The blood usage and requirements have an 
affect on capacity in the National Blood 
Centre and each individual Blood 
Transfusion Laboratory. 
Legal 
While there is no specific legal framework 
for the provision of blood surrounding 
wastage or misuse, it is the responsibility 
of all Transfusion laboratories to ensure 
they maximise the provision of blood for 
all users. 
Ethical 
The IBTS states in their mission statement 
that: ‘The IBTS is committed to excellence 
in meeting patients’ needs through the 
professionalism of our staff and the 
generosity of our donors.’ 
Note: PESTLE analysis can be useful before SWOT analysis because PESTLE helps to identify SWOT factors. PESTLE and SWOT are two different perspectives but can 
contain common factors 
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Appendix 4 SWOT Analysis 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weaknesses 
• Resistance 
 
• Time 
 
• Large volume of data 
 
• Low Moral 
 
Opportunities 
• Reduction on Blood 
wastage 
 
• Reduced workload 
 
 
• Cost Saving 
 
Threats 
• Culture 
 
• Resistence from high 
powered clinicians 
 
• No support 
 
• IT system 
Strengths 
• Core of competent staff 
 
• System in place to be 
modified 
 
• Economic issues 
 
• Savings in time cost and 
time 
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Appendix 5 Stakeholder Analysis 
 
Stakeholder Job Role Project Role Interest* Why?* Impact* Responsibil
ity* 
Readines
s* 
Capacity
* 
Directorate 
Manager 
To oversee the 
Laboratory Directorate 
as a whole. 
Limited role in 
the project 
Medium Awareness Medium Medium Low Low 
Laboratory 
Manager 
To oversee the running 
of the Laboratory 
including staff 
Limited role in 
the project 
Medium Too Busy Medium Medium Low Low 
 
Chief Medical 
Scientist 
To oversee the running 
of the Blood Transfusion 
Department 
Substantial 
role in the 
project 
High Project 
Credibility 
High High High High 
Medical 
Scientist 
To cover all functions of 
the Transfusion 
laboratory 
Substantial 
role in the 
project 
High Awareness Medium Low High High 
Anaesthetic 
Staff 
To provide Anaesthetic 
support for all surgery 
patients. 
Substantial 
role in the 
project 
Medium Project 
Credibility 
High High Medium High 
Theatre 
Admission staff 
To admit all patients to 
theatre based on agreed 
checklists for entry. 
Medium role in 
the project 
Medium Awareness Medium Low Medium Medium 
Day of Surgery 
Admission 
Ward 
To provide an entry 
route to the hospital for 
patients who do not 
require a hospital stay. 
Medium role in 
the project 
Medium Awareness Medium Low Medium Medium 
Interns To provide work ups for 
patients presenting to 
theatre based on 
individual teams 
requirements 
Medium role in 
the project 
High Understandi
ng 
High Medium Medium Medium 
Author To cover all functions  of 
the Transfusion 
Laboratory 
High High Personal 
Impact 
Medium High High High 
 
 
 
 
 
 
 
 
63 
 
Appendix 6 Poster 
 
64 
 
Appendix 7 Gantt Chart 
